Biostimulator Indication Growth (Ellansé, Lanluma)

About Sinclair Pharma

Sinclair Pharma is an established, commercial-stage player in the global medical aesthetics market, offering a diversified portfolio of injectable dermal fillers (e.g., MaiLi, Perfectha, Ellansé) and energy-based devices (e.g., Cooltech, Primelase). Uniquely positioned as a 'holistic aesthetics' provider, it supports the full patient journey with a science-backed product range sold in over 55 countries. Following its 2018 acquisition by Chinese pharmaceutical giant Huadong Medicine, Sinclair benefits from expanded resources and access to key markets while maintaining its operational focus on innovation and clinician education.

Therapeutic Areas